Helicobacter pylori eradication or antisecretory therapy for rebleeding from peptic ulcer
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Helicobacter Pylori Eradication or Antisecretory Therapy for Rebleeding From Peptic Ulcer." Evidence-Based Medicine Guidelines, Duodecim Medical Publications Limited, 2019. Evidence Central, evidence.unboundmedicine.com/evidence/view/EBMG/455144/1/images/closex.png.
Helicobacter pylori eradication or antisecretory therapy for rebleeding from peptic ulcer. Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. https://evidence.unboundmedicine.com/evidence/view/EBMG/455144/1/images/closex.png. Accessed May 4, 2024.
Helicobacter pylori eradication or antisecretory therapy for rebleeding from peptic ulcer. (2019). In Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited. https://evidence.unboundmedicine.com/evidence/view/EBMG/455144/1/images/closex.png
Helicobacter Pylori Eradication or Antisecretory Therapy for Rebleeding From Peptic Ulcer [Internet]. In: Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. [cited 2024 May 04]. Available from: https://evidence.unboundmedicine.com/evidence/view/EBMG/455144/1/images/closex.png.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Helicobacter pylori eradication or antisecretory therapy for rebleeding from peptic ulcer
ID - 455144
BT - Evidence-Based Medicine Guidelines
UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/455144/1/images/closex.png
PB - Duodecim Medical Publications Limited
DB - Evidence Central
DP - Unbound Medicine
ER -